CORT | Corcept Therapeutics Incorporated Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	56.15 - 57.71
52 Week Range	20.84 - 61.66
Beta	0.45
Implied Volatility	64.47%
IV Rank	30.74%
Day's Volume	648,547
Average Volume	958,526
Shares Outstanding	104,775,000
Market Cap	6,028,753,500
Sector	Healthcare
Industry	Biotechnology
IPO Date	2004-04-14

Valuation
Profitability
Growth
Health
P/E Ratio	45.67
Forward P/E Ratio	28.23
EPS	1.26
1YR Price Target	33.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	352
Country	USA
Website	CORT

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

CORT's peers: CGC, IDYA, ANAB, MGTX, KROS, FIXX, EWTX, GLUE, MLYS, ERAS, HALO, AGIO, INSM, CERE, RARE, CYTK, DICE, KRTX, DYN, SNSE, NXTC, NUVB, GRPH, MACK

*Chart delayed

Analyzing fundamentals for CORT we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is good and Health is strong. For more detailed analysis please see CORT Fundamentals page.

Watching at CORT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on CORT Technicals page.